Among them, SRSF1 promotes the inclusion of CD33 exons in Alzheimer’s disease to enhance the transcription and expression of full-length CD33 and regulates their specific interaction with CD33 pre-mRNA, thus altering the protein levels on the cell surface35. Here, CD33 is linked to early-onset autosomal dominant Alzheimer disease.